FORNI, Flavio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 36.225
EU - Europa 20.562
AS - Asia 16.140
SA - Sud America 2.243
AF - Africa 418
OC - Oceania 48
Continente sconosciuto - Info sul continente non disponibili 27
Totale 75.663
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 35.717
GB - Regno Unito 6.628
IT - Italia 4.614
SG - Singapore 4.566
CN - Cina 4.494
SE - Svezia 3.764
HK - Hong Kong 2.084
BR - Brasile 1.685
VN - Vietnam 1.668
DE - Germania 1.143
TR - Turchia 810
UA - Ucraina 801
FI - Finlandia 735
RU - Federazione Russa 709
FR - Francia 673
KR - Corea 543
IN - India 406
BD - Bangladesh 363
BG - Bulgaria 314
CA - Canada 225
NL - Olanda 201
AR - Argentina 176
JP - Giappone 161
MX - Messico 159
RO - Romania 151
IQ - Iraq 143
ZA - Sudafrica 132
IE - Irlanda 129
ID - Indonesia 127
ES - Italia 112
PL - Polonia 109
PK - Pakistan 98
BE - Belgio 93
AE - Emirati Arabi Uniti 87
EC - Ecuador 87
CO - Colombia 85
CH - Svizzera 66
MY - Malesia 64
TH - Thailandia 60
VE - Venezuela 59
MA - Marocco 57
CL - Cile 56
IR - Iran 50
DZ - Algeria 48
LT - Lituania 48
EG - Egitto 46
PH - Filippine 42
UZ - Uzbekistan 42
AU - Australia 40
SA - Arabia Saudita 40
IL - Israele 37
CZ - Repubblica Ceca 36
JO - Giordania 36
PT - Portogallo 36
NP - Nepal 35
PE - Perù 34
TN - Tunisia 34
PY - Paraguay 30
AT - Austria 28
KE - Kenya 27
TW - Taiwan 26
AZ - Azerbaigian 25
GR - Grecia 23
JM - Giamaica 23
EU - Europa 20
KZ - Kazakistan 20
SN - Senegal 19
DO - Repubblica Dominicana 17
ET - Etiopia 17
MD - Moldavia 17
BO - Bolivia 16
DK - Danimarca 16
AL - Albania 14
UY - Uruguay 14
LB - Libano 13
OM - Oman 13
CR - Costa Rica 12
RS - Serbia 12
TT - Trinidad e Tobago 12
BY - Bielorussia 11
HU - Ungheria 11
LV - Lettonia 10
NO - Norvegia 10
PA - Panama 10
KG - Kirghizistan 9
EE - Estonia 8
GT - Guatemala 8
HR - Croazia 8
NZ - Nuova Zelanda 8
BH - Bahrain 7
CY - Cipro 7
HN - Honduras 7
NI - Nicaragua 7
PR - Porto Rico 7
PS - Palestinian Territory 7
SI - Slovenia 7
AM - Armenia 6
AO - Angola 6
KH - Cambogia 6
LK - Sri Lanka 6
Totale 75.538
Salva come PNG Salva come JPEG
Città #
Southend 5.220
Santa Clara 3.372
Ashburn 3.289
Singapore 2.874
Fairfield 2.618
Chandler 2.172
Hong Kong 2.047
Woodbridge 1.903
Stockholm 1.816
Jacksonville 1.620
Hefei 1.443
Houston 1.326
Chicago 1.259
Dearborn 1.215
San Jose 1.201
Wilmington 1.108
Seattle 1.068
Nyköping 1.060
Ann Arbor 1.049
Beijing 888
Cambridge 883
Los Angeles 766
London 735
Council Bluffs 548
Ho Chi Minh City 542
Modena 485
Izmir 465
Seoul 462
Helsinki 441
The Dalles 435
Hanoi 397
Milan 356
New York 356
Salt Lake City 337
Princeton 324
Sofia 301
Eugene 276
Des Moines 249
Dallas 243
San Diego 237
Lauterbourg 231
Buffalo 216
Rome 213
Moscow 182
Redwood City 180
Shanghai 154
São Paulo 147
Bremen 146
Tampa 142
Elk Grove Village 135
Orem 133
Tokyo 120
Munich 118
Dublin 108
Fremont 104
Columbus 98
Bologna 96
Boardman 94
Frankfurt am Main 94
Chennai 86
Phoenix 84
Naples 83
Brussels 80
Falls Church 76
Guangzhou 76
Lancaster 75
Jakarta 70
Da Nang 69
Johannesburg 65
Sterling 65
Haiphong 62
Warsaw 61
Miami 59
Atlanta 56
Parma 56
Brooklyn 54
Norwalk 54
Denver 52
Toronto 52
Washington 52
Florence 51
Baghdad 50
Como 49
Nanjing 48
Turin 48
Dulles 47
Montreal 47
Amsterdam 46
Miano 46
Detroit 45
Kunming 45
Rio de Janeiro 43
Bari 42
Reggio Emilia 42
Mexico City 41
Belo Horizonte 40
Mumbai 39
Napoli 39
Redondo Beach 38
Quito 37
Totale 52.367
Salva come PNG Salva come JPEG
Nome #
A novel phytocannabinoid isolated from Cannabis sativa L. with an in vivo cannabimimetic activity higher than Δ9-tetrahydrocannabinol: Δ9-Tetrahydrocannabiphorol 2.310
AFM/TEM complementary structural analysis of surface-functionalized nanoparticles 583
Nanovettori lipidici e polimerici per la somministrazione sito-specifica di farmaci antitumorali 506
Can leptin-derived sequence-modified nanoparticles be suitable tools for brain delivery? 493
Cristallinità ed equivalenza nel cloramfenicolo palmitato 488
Analysis of cannabinoids in commercial hemp seed oil and decarboxylation kinetics studies of cannabidiolic acid (CBDA) 481
Targeting the Central Nervous System: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123 466
Nanoimaging: photophysical and pharmaceutical characterization of poly-lactide-co-glycolide nanoparticles engineered with quantum dots 459
Flow cytometry and live confocal analysis for the evaluation of the uptake and intracellular distribution of FITC-ODN into HaCaT cells 455
Exploiting Bacterial Pathways for BBB Crossing with PLGA Nanoparticles Modified with a Mutated Form of Diphtheria Toxin (CRM197): In Vivo Experiments 435
AFM, ESEM, TEM and CLSM in liposomal characterization: a comparative study 431
Development of a simple and sensitive liquid chromatography triple quadrupole mass spectrometry (LC–MS/MS) method for the determination of cannabidiol (CBD), Δ9-tetrahydrocannabinol (THC) and its metabolites in rat whole blood after oral administration of a single high dose of CBD 426
Cationic liposomes for gene transfection 420
Characterization of lysosome-destabilizing DOPE/PLGA nanoparticles designed for cytoplasmic drug release 420
NUTRASCIENCE s.r.l. 420
Nanoparticulate drug carriers based on hybrid poly(D,L-lactide-co-glycolide)-dendron structures 419
NANOPARTICELLE IBRIDE PLGA/DOPE: STUDI DI TRANSFEZIONE, ESCAPE ENDOSOMIALE E TRAFFICKING CELLULARE 416
NIR-labeled nanoparticles engineered for brain targeting: in vivo optical imaging application and fluorescent microscopy evidences. 416
Nanotechnology and Alzheimer’s disease: What has been done and what to do’ 414
Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: In vivo pharmacological evidence and biodistribution 405
Use of Polylactide-Co-Glycolide-Nanoparticles for Lysosomal Delivery of a Therapeutic Enzyme in Glycogenosis Type II Fibroblasts 398
Apoferritin nanocage as streptomycin drug reservoir: Technological optimization of a new drug delivery system 395
Chemico-physical investigation of tenofovir loaded polymeric nanoparticles 395
Poly (D,L-lactide-co-glycolide) nanoparticles loaded with Cerebrolysin display neuroprotective activity in a rat model of closed head injury 394
PEG-g-chitosan nanoparticles functionalized with the monoclonal antibody OX26 for brain drug targeting 393
Sialic Acid as a potential approach for the protection and targeting of nanocarriers 392
Collagen modified based membranes for tissue engineering: influence of type and molecular weight of GAGs on cell proliferation 385
Peptide-derivatized biodegradable nanoparticles able to cross the blood-brain barrier 381
AFM phase imaging of soft-hydrated samples: A versatile tool to complete the chemical-physical study of liposomes 372
Analysis of impurities of cannabidiol from hemp. Isolation, characterization and synthesis of cannabidibutol, the novel cannabidiol butyl analog 370
Insight on the fate of CNS-targeted nanoparticles. Part II: Intercellular neuronal cell-to-cell transport 367
Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles 366
Polymeric nanoparticles for the drug delivery to the central nervous system 364
A Nanoparticle-based approach for drug delivery to the brain in Lysosomal Storage Disorders 363
Current Strategies for the Delivery of Therapeutic Proteins and Enzymes to Treat Brain Disorders 362
Distribution of drugs in polymers loaded by swelling 361
Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution 357
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity 357
Application of Polymeric Nanoparticles for CNS Targeted Zinc Delivery In Vivo 355
Complessazione di SiRNA anti Blimp-1/PRDM con liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di PEL 352
Protein corona and nanoparticles: How can we investigate on? 351
Diffusione di derivati dell\'acido benzoico attraverso membrane lipidiche in presenza di Tween 80 349
Flow Cytometry and live confocal analysis in the evaluation of uptake and intracellular distribution of FITC-ODN into HaCaT cells 348
Protein cage nanostructure as drug delivery system: magnifying glass on apoferritin 347
Microwave-treated gelatin microspheres as drug delivery system 343
Nanoparticle transport across the blood brain barrier 343
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma 341
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes 340
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 340
The loading of labeled antibody engineered nanoparticles with Indinavir increases its in vitro efficacy against Cryptosporidium parvum 338
Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma 336
The grinding of the polymorphic forms of chloramphenicol stearic ester in the presence of colloidal silica 334
Biodisponibilità e bioequivalenza in compresse commerciali di nitrofurantoina 332
Anticancer drug-loaded quantum dots engineered polymeric nanoparticles: Diagnosis/therapy combined approach 332
Isolation of a High-Affinity Cannabinoid for the Human CB1 Receptor from a Medicinal Cannabis sativa Variety: Δ9-Tetrahydrocannabutol, the Butyl Homologue of Δ9-Tetrahydrocannabinol 332
Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery 331
Qualitative and semiquantitative analysis of the protein coronas associated to different functionalized nanoparticles 330
NANOPARTICELLE POLIMERICHE PER LA VEICOLAZIONE DI MACROMOLECOLE PROTEICHE: STUDI PRELIMINARI DI CARATTERIZZAZIONE TECNOLOGICA 330
Peptide-engineered polylactide-co-glycolide (PLGA) nanoparticles for brain delivery of drugs: in vivo experiments and proof of concept 329
AFM and TEM characterization of siRNAs lipoplexes: a combinatory tools to predict the efficacy of complexation 329
Investigation on Mechanisms of Glycopeptide Nanoparticles for Drug Delivery across the Blood-Brain Barrier 329
NANOMEDICINE IN NEUROSCIENCE: THE POTENTIAL OF TARGETED NANOPARTICLES IN NEURODEGENERATIVE DISORDERS 326
Cannabinoid profiling of hemp seed oil by liquid chromatography coupled to high-resolution mass spectrometry 326
A theoretical model for the calculation of the drug distribution profile in matrices of different shape to achieve the desired drug release kinetics 325
Untargeted rat brain metabolomics after oral administration of a single high dose of cannabidiol 324
Conjugated poly(D,L-lactide-co-glycolide) for the preparation of in vivo detectable nanoparticles 324
How does “Protein Corona” Affect the In vivo Efficiency of Polymeric Nanoparticles? State of Art 323
Dotap/Udca vesicles: novel approach in oligonucleotide delivery 322
Identification of a new cannabidiol n-hexyl homolog in a medicinal cannabis variety with an antinociceptive activity in mice: cannabidihexol 322
Development and characterization of biodegradable nanospheres as delivery systems of anti-ischemic adenosine derivatives 318
Glioblastoma: State of the Art of Treatments and Applications of Polymeric and Lipidic Nanomedicines 316
Nanoparticles engineered with rituximab and loaded with Nutlin-3 show promising therapeutic activity in B-leukemic xenografts. 315
Brain targeting by engineered nanoparticles: in vivo and in vitro evidences 314
Liposome-oligonucleotides interaction for in vitro uptake by COSI and HaCaT cells 313
Development of novel Zn2+ loaded nanoparticles designed for cell-type targeted drug release in CNS neurons: in vitro evidences. 312
PLGA Nanoparticles Loaded Cerebrolysin: Studies on Their Preparation and Investigation of the Effect of Storage and Serum Stability with Reference to Traumatic Brain Injury 311
PLGA-PEG-ANG-2 Nanoparticles for Blood-Brain Barrier Crossing: Proof-of-Concept Study 310
Brain-targeted polymeric nanoparticles: In vivo evidence of different routes of administration in rodents 309
Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice 308
Targeted polymeric nanoparticles for brain delivery of high molecular weight molecules in lysosomal storage disorders 306
Chemical and spectroscopic characterization data of ‘cannabidibutol’, a novel cannabidiol butyl analog 306
NANOPARTICELLE POLIMERICHE PER IL DIREZIONAMENTO CEREBRALE: DELIVERY DI ZINCO E STUDI PRELIMINARI IN VITRO SU CELLULE NEURONALI 305
Nanoparticles for brain delivery of drugs: in vivo experiments andmechanism of BBB crossing 304
Functionalization of liposomes: microscopical methods for preformulative screening 304
Potential Use of Nanomedicine for Drug Delivery Across the Blood-Brain Barrier in Healthy and Diseased Brain 304
Colloidal systems for CNS drug delivery 299
Acidi colici nella preparazione di liposomi cationici per la transfezione in cellule HaCaT 298
Applicazione delle tecniche microscopiche, spettroscopiche e calorimetriche nella caratterizzazione di nanoparticelle funzionalizzate 296
Biodegradable device applied in flatfoot surgery: Comparative studies between clinical and technological aspects of removed screws 295
Pitfalls in the analysis of phytocannabinoids in cannabis inflorescence 294
EXPLOITING THE VERSATILITY OF CHOLESTEROL IN NANOPARTICLES FORMULATION 293
Atomic force microscopy and photon correlation spectroscopy: Two techniques for rapid characterization of liposomes 293
A solution and solid state study on 2-hydroxypropyl-beta-cyclodextrin complexation with hyodeoxycholic acid 289
Pseudomorfosi nel cloramfenicolo stearato e palmitato in relazione alla disponibilità 289
AN INTERPRETATIVE ANALYSIS OF THE EFFECT OF THE SURFACTANTS USED FOR THE PREPARATION OF POLYALKYLCYANOACRYLATE NANOPARTICLES ON THE RELEASE PROCESS 288
Activitè enzymatique de la pancréatine de formes pharmaceutiques: une nouvelle méthode d'évaluation 286
ROS-responsive “smart” polymeric conjugate: Synthesis, characterization and proof-of-concept study 283
Preformulative and formulative studies on inclusion complexes between cyclodextrins and ursodeoxycholic acid 280
Papaverine hydrochloride release from ethyl cellulose-walled microcapsules 280
A DELIVERY SYSTEM FOR THE CONCURRENT ADMINISTRATION OF HYDROCHLOROTHIAZIDE AND CAPTOPRIL 280
Totale 37.316
Salva come PNG Salva come JPEG
Categoria #
all - tutte 268.214
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 268.214
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021342 0 0 0 0 0 0 0 0 0 0 0 342
2021/20225.275 221 631 486 430 173 261 274 296 604 387 871 641
2022/20236.271 749 683 534 609 764 980 160 525 673 96 225 273
2023/20243.890 185 227 226 295 816 391 468 527 138 118 173 326
2024/202512.486 647 183 264 943 2.567 1.738 895 819 1.177 476 1.302 1.475
2025/202623.715 1.437 785 1.782 2.776 4.171 1.590 2.383 1.060 4.114 2.108 1.245 264
Totale 76.104